Guardant Health Inc (NAS:GH)
$ 23.38 -0.22 (-0.93%) Market Cap: 2.88 Bil Enterprise Value: 3.20 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Guardant Health Inc Investor Day Transcript

Sep 07, 2023 / 12:00PM GMT
Release Date Price: $35.28 (+2.62%)
Unidentified Company Representative

(presentation)

Please welcome to the stage, the co-CEOs of Guardant Health: Helmy Eltoukhy and AmirAli Talasaz.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, Co-CEO & Chairman

Well, thank you for joining us at our inaugural Investor Day today. It's been 5 years since our IPO. And looking back, it's really remarkable how much we've accomplished in those 5 short years. Given where we are today, we felt it's a good time to refresh the story and share what we expect the Guardant road map to look like for the next 5 years.

Here's our safe harbor statement. We'll be making some forward-looking comments.

And here's the agenda for today. We have a pretty action-packed day. We are going to dive into smart liquid biopsy and talking a little bit about how that technology works. And then we'll give an update on each of our businesses: Therapy Selection, MRD. We'll talk about our platform for commercialization on the oncology side and then give you a chance for a little bit of Q&A. Short break. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot